New blood tester aims to spot red cell damage faster
NCT ID NCT07345091
First seen Jan 21, 2026 · Last updated May 17, 2026 · Updated 17 times
Summary
This study tests a new device, the ABL90 FLEX PLUS HEM, to see how well it can detect hemolysis (damage to red blood cells) in blood samples. About 95 adults will provide blood samples, which will be checked by the device and compared to standard lab methods. The goal is to see if the device can correctly classify the level of hemolysis, which could help doctors get more accurate test results.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Bispebjerg Hospital
RECRUITINGCopenhagen, NV, 2400, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.